The patients received bacteriophage therapy with a liquid piobacteriophage complex (liquid
pyobacteriophage complex - PCL). PСL was administered via nebulizer inhalation to irrigate
the tonsil mucosa. A total of 5 ml of PCL was inhaled for 10 minutes every 5 days. The drug
causes the lysis of certain bacteria, including staphylococcus, enterococcus, streptococcus,
enteropathogenic E. coli, Proteus vulgaris, Proteus mirabilis, Pseudomonas aeruginosa,
Klebsiella pneumoniae and Klebsiella oxytoca. The choice of this drug was based on
bacteriological studies.